Personalized medicine: the future is here.
作者信息
Primorac Dragan, Ciechanover Aaron
机构信息
Dragan Primorac, St. Catherine Hospital, Zagreb, Croatia,
出版信息
Croat Med J. 2024 Jun 13;65(3):169-173. doi: 10.3325/cmj.2024.65.169.
Abstract
摘要
相似文献
1
Personalized medicine: the future is here.个性化医疗：未来已来。
Croat Med J. 2024 Jun 13;65(3):169-173. doi: 10.3325/cmj.2024.65.169.
2
Is precision medicine the future of healthcare?精准医疗是医疗保健的未来吗？
Per Med. 2017 Nov;14(6):459-461. doi: 10.2217/pme-2017-0060. Epub 2017 Nov 24.
3
The computable cell: A step toward personalized medicine.可计算细胞：迈向个性化医疗的一步。
Sci Signal. 2015 Dec 22;8(408):eg6. doi: 10.1126/scisignal.aae0544.
4
Personalized medicine going precise: from genomics to microbiomics.精准化个性化医疗：从基因组学到微生物组学
Trends Mol Med. 2015 Aug;21(8):461-2. doi: 10.1016/j.molmed.2015.06.002. Epub 2015 Jun 27.
5
Personalized medicine in Austria: expectations and limitations.奥地利的个性化医疗：期望与局限
Per Med. 2020 Nov;17(6):423-428. doi: 10.2217/pme-2020-0061. Epub 2020 Oct 7.
6
Future directions in overactive bladder treatment: Personalized medicine can be applied?膀胱过度活动症治疗的未来方向：个性化医疗能否应用？
Korean J Urol. 2015 Oct;56(10):671-2. doi: 10.4111/kju.2015.56.10.671. Epub 2015 Oct 13.
7
Ready or not: personalized medicine is coming. IEEE Pulse talks with Michael Snyder about its potential.准备好了吗：个性化医疗即将到来。《IEEE 脉动》杂志与迈克尔·斯奈德探讨了其潜力。
IEEE Pulse. 2014 May-Jun;5(3):45-7. doi: 10.1109/MPUL.2014.2309580.
8
From personalized to precision cancer medicine.从个性化癌症医学到精准癌症医学。
Per Med. 2020 Jul 1;17(4):245-250. doi: 10.2217/pme-2020-0056. Epub 2020 Jun 26.
9
New tech for personalized medicine.个性化医疗的新技术。
Biotechniques. 2019 Feb;66(2):59. doi: 10.2144/btn-2019-0007.
10
Personalized medicine in cancer: where are we today?癌症个性化医疗：我们如今处于什么阶段？
Future Oncol. 2015;11(20):2795-8. doi: 10.2217/fon.15.204. Epub 2015 Sep 7.
引用本文的文献
1
Amplification-Free Testing of microRNA Biomarkers in Cancer.癌症中微小RNA生物标志物的无扩增检测
Cancers (Basel). 2025 Aug 21;17(16):2715. doi: 10.3390/cancers17162715.
2
Preliminary insight into the potential role of Leptin Receptor Polymorphisms in Type 2 Diabetes Risk: case-control study and bioinformatics analysis.瘦素受体基因多态性在2型糖尿病风险中的潜在作用的初步见解：病例对照研究和生物信息学分析
J Diabetes Metab Disord. 2025 May 3;24(1):113. doi: 10.1007/s40200-025-01617-5. eCollection 2025 Jun.
3
The future of medicine: embracing novelty while sticking to the basics.医学的未来：拥抱创新，坚守基础。
Croat Med J. 2025 Feb 28;66(1):1-2. doi: 10.3325/cmj.2025.66.1.
本文引用的文献
1
Implementing Whole Genome Sequencing (WGS) in Clinical Practice: Advantages, Challenges, and Future Perspectives.在临床实践中实施全基因组测序（WGS）：优势、挑战和未来展望。
Cells. 2024 Mar 13;13(6):504. doi: 10.3390/cells13060504.
2
Utilization of the microbiome in personalized medicine.利用微生物组进行个性化医疗。
Nat Rev Microbiol. 2024 May;22(5):291-308. doi: 10.1038/s41579-023-00998-9. Epub 2023 Dec 18.
3
Novel Approach in Rectovaginal Fistula Treatment: Combination of Modified Martius Flap and Autologous Micro-Fragmented Adipose Tissue.直肠阴道瘘治疗的新方法：改良马蒂厄皮瓣与自体微片段脂肪组织联合应用
Biomedicines. 2023 Sep 11;11(9):2509. doi: 10.3390/biomedicines11092509.
4
Circulating tumor DNA: current challenges for clinical utility.循环肿瘤 DNA：临床应用的当前挑战。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI154941.
5
Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report.COVID-19 重症患者的同情性间充质干细胞治疗：病例报告。
Croat Med J. 2021 Jun 30;62(3):288-296. doi: 10.3325/cmj.2021.62.288.
6
Germline and somatic mutation profile in Cancer patients revealed by a medium-sized pan-Cancer panel.通过一个中等规模的泛癌基因检测板揭示癌症患者的种系和体细胞突变谱。
Genomics. 2021 Jul;113(4):1930-1939. doi: 10.1016/j.ygeno.2021.04.029. Epub 2021 Apr 18.
7
Health and disease markers correlate with gut microbiome composition across thousands of people.健康和疾病标志物与数千人的肠道微生物组组成相关。
Nat Commun. 2020 Oct 15;11(1):5206. doi: 10.1038/s41467-020-18871-1.
8
Pharmacogenomics at the center of precision medicine: challenges and perspective in an era of Big Data.精准医学的核心：大数据时代的挑战与展望。
Pharmacogenomics. 2020 Jan;21(2):141-156. doi: 10.2217/pgs-2019-0134. Epub 2020 Jan 17.
9
Differences between germline and somatic mutation rates in humans and mice.人类和小鼠种系与体细胞突变率的差异。
Nat Commun. 2017 May 9;8:15183. doi: 10.1038/ncomms15183.
10
CAR T cells for solid tumors: armed and ready to go?用于实体瘤的嵌合抗原受体T细胞：准备就绪了吗？
Cancer J. 2014 Mar-Apr;20(2):151-5. doi: 10.1097/PPO.0000000000000032.
Zotero 插件